ASPEN-09

Who Can Participate in the Study?

Age Group
Adults

Study Details

Full Title
A Phase 1b/2, Open-label, Multicenter, Multi Arm Study of Evorpacept in Combination with Anti-cancer Therapies in Advanced / Metastatic Malignancies (ASPEN-09)
Principal Investigator
Headshot of Carey Kernodle Anders
Professor of Medicine
Protocol Number
IRB: PRO00119152
NCT: NCT07007559
Phase
Phase I/II
ClinicalTrials.gov
Status
OPEN TO ACCRUAL